Rajesh Tope, Maharashtra’s health minister has said that the price of Remdesivir, the anti-viral drug that is also used for Covid-19 treatment, should be slashed to Rs 1,200- Rs 1,300. Tope also stated that Remdesivir manufacturers should double the production of the drug.
“Companies manufacturing anti-viral drug Remdesivir should double the production and decrease its Maximum Retail Price (MRPs) to Rs 1200-Rs1300,” news agency ANI quoted Tope as saying. The anti-viral drug Remdisivir, reportedly, is being sold in the price range of Rs 2,400 to 6,000.
Earlier Tope had stated that Maharashtra has been using a daily dose of 50,000 Remdesivir and that the state required a significantly higher number of doses. Amidst a spike in Covid-19 cases, Maharashtra has been confronting the shortage of Remdesivir. In a bid to manage the shortage situation and prevent black-marketing as well as hoarding of these drugs, the state government had made a decision for setting up district-level control rooms for ensuring a smooth supply of injections.
The union government, on 11 April, had barred exports of Remdesivir and Remdesivir Active Pharmaceutical Ingredients considering the new surge of Covid-19 in the country.